Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
CARGO Therapeutics, Inc. (CRGX)
NASDAQ:CRGX
RESEARCH TOOLSreports
Holding CRGX?
Track your performance easily
See the Price Targets and Ratings of:
CRGX Analyst Ratings
Strong Buy
4 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
CRGX Stock 12 Month Forecast
Average Price Target
$32.25
▲(44.23% Upside)
| Highest Price Target$34.00 | Average Price Target$32.25 | Lowest Price Target$30.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Piper Sandler
Assigned
11/06/24
J.P. Morgan
Reiterated
10/10/24
Truist Financial
Reiterated
08/14/24
H.C. Wainwright
Reiterated
08/13/24
Chardan Capital
$28
Buy
25.22%
Upside
Initiated
07/08/24
Buy Rating Affirmed for CARGO Therapeutics on Promising CAR-T Advancements and Strategic Positioning
Jefferies
$28
Buy
25.22%
Upside
Reiterated
12/13/23
We like CRGX into 2024 in a year of execution and key Phase IIB interim data is in 2025. New data at ASH shows extended durability of CRG-022 and should bode well for ongoing enrollment of the potentially pivotal Phase II study. Recall CRGX licensed the lead program CRG-022 from Stanford where the Phase I study was conducted. In 38 pts who failed prior CD19 targeted therapy, CRG-022 had shown a 53% (20/38) CR and 68% (26/38) with a median of 22.8m of follow up, through which 17/20 pts (85%) had stayed in remission. New data at ASH included 5 add'l months of follow up, and 16/20 (80%) pts remains in remission at median follow up of 27.3m. Moreover, the median OS at the go forward dose (DL1) is still maturing which suggests it could go out further than the 14.1m mOS of DL2.
Best Analysts Covering CARGO Therapeutics, Inc.
Which Analyst Should I Follow If I Want to Buy CRGX and Sell After:
1 Month
xxx
Success Rate
3/4 ratings generated profit
Average Return
+13.78%
assigned a xxx
rating 4 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 75.00% of your transactions generating a profit, with an average return of +13.78% per trade.
3 Months
xxx
Success Rate
4/4 ratings generated profit
Average Return
+16.05%
assigned a xxx
rating 4 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +16.05% per trade.
1 Year
Success Rate
3/3 ratings generated profit
Average Return
+27.43%
reiterated a buy rating 3 months ago
Copying Asthika Goonewardene's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +27.43% per trade.
2 Years
xxx
Success Rate
3/3 ratings generated profit
Average Return
+27.43%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +27.43% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
CRGX Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
4
6
6
5
3
Buy
2
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
6
6
6
5
3
Each month's total comprises the sum of three months' worth of ratings.
CRGX Financial Forecast
CRGX Stock Forecast FAQ
What is CRGX’s average 12-month price target, according to analysts?
Based on analyst ratings, CARGO Therapeutics, Inc.’s 12-month average price target is $32.25.
What is CRGX’s upside potential, based on the analysts’ average price target?
CARGO Therapeutics, Inc. has 44.23% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CRGX a Buy, Sell or Hold?
CARGO Therapeutics, Inc. has a consensus rating of Strong Buy which is based on 4 buy ratings, 0 hold ratings and 0 sell ratings.
What is CARGO Therapeutics, Inc.’s price target?
The average price target for CARGO Therapeutics, Inc. is $32.25. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $34.00 ,the lowest forecast is $30.00. The average price target represents 44.23% Increase from the current price of $22.36.
The highest analyst price target is $34.00 ,the lowest forecast is $30.00. The average price target represents 44.23% Increase from the current price of $22.36.
What do analysts say about CARGO Therapeutics, Inc.?
CARGO Therapeutics, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
How can I buy shares of CRGX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.